| Dr Bethanny R Glahn, MD | |
|
18511 Highlander Medics St, Wbamc, Mchm-dos-gsr, El Paso, TX 79906 | |
| (915) 742-0730 | |
| (915) 742-7889 |
| Full Name | Dr Bethanny R Glahn |
|---|---|
| Gender | Female |
| Speciality | General Practice |
| Location | 18511 Highlander Medics St, Wbamc, El Paso, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295394898 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 33579 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bethanny R Glahn, MD 18511 Highlander Medics St, Wbamc, Mchm-dos-gsr, El Paso, TX 79906 Ph: (915) 742-0730 | Dr Bethanny R Glahn, MD 18511 Highlander Medics St, Wbamc, Mchm-dos-gsr, El Paso, TX 79906 Ph: (915) 742-0730 |
News Archive
Even as health overhaul drama continues on Capitol Hill, news outlets continue to watch how developments at the state level will impact the law's implementation.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, will deliver four poster presentations on its compounds at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
Geriatric conditions such as frailty and cognitive impairments may inadvertently worsen when older patients are treated in cardiac intensive care units - even as they receive excellent care for their heart attack, heart failure, valvular heart disease or pulmonary embolism, according to a new scientific statement from the American Heart Association, published today in the Association's premier journal Circulation.
ConjuChem, LLC, a biotechnology company dedicated to the discovery of novel therapeutics, today announced it has initiated patient enrollment for its Phase 2 clinical trial of its proprietary GLP-1 receptor agonist drug, CJC-1134-PC, in patients with Type 2 diabetes mellitus who are receiving metformin monotherapy.
› Verified 1 days ago
Yvonne Elizabeth Hernandez, General Practice Medicare: Medicare Enrolled Practice Location: 7500 N Mesa St Ste 210, El Paso, TX 79912 Phone: 915-307-7800 Fax: 915-351-4001 | |
Dr. Thomas M Crowell Ii, D.O. General Practice Medicare: Accepting Medicare Assignments Practice Location: 10301 Gateway Blvd W, El Paso, TX 79925 Phone: 203-313-4918 | |
Dr. Patricia C Nelson, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 2000 Trans Mountain Rd Fl 3b, El Paso, TX 79911 Phone: 915-215-8400 Fax: 915-612-9253 | |
Dr. Harold Morris Block Jr., M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 2126 Montana Ave, El Paso, TX 79903 Phone: 915-838-8484 Fax: 915-351-2203 | |
Denise Lavette Deshields, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 3901 State Jail Rd, El Paso, TX 79938 Phone: 915-849-8039 Fax: 915-849-8465 | |
Dr. Benson Chee, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 8613 Westline Dr, El Paso, TX 79904 Phone: 210-843-9557 | |
Gary Craig Jarvis, D.O. General Practice Medicare: Medicare Enrolled Practice Location: 4815 Alameda Ave, El Paso, TX 79905 Phone: 915-215-5666 Fax: 915-215-5047 |